Similar Papers

Paper Title
Journal
Date
Author
Long Noncoding RNA LINC01133 Functions as an miR-422a Sponge to Aggravate the Tumorigenesis of Human Osteosarcoma.
Hai-Feng Zeng ... Fa-Bo Feng
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics | VOL. 26
Hai-Feng Zeng, et. al.Hai-Feng Zeng ... Fa-Bo Feng
10 Apr 2018
Long Noncoding RNA DICER1-AS1 Functions in Methylation Regulation on the Multi-Drugresistance of Osteosarcoma Cells via miR-34a-5p and GADD45A.
Feng Wang ... Fengmei Chao
Frontiers in oncology | VOL. 11
Feng Wang, et. al.Feng Wang ... Fengmei Chao
09 Jul 2021
Different roles for the adjoining and structurally similar A-rich and poly(A) domains of oskar mRNA: Only the A-rich domain is required for oskar noncoding RNA function, which includes MTOC positioning
Andrew Kenny ... Paul M Macdonald
Developmental Biology | VOL. 476
Andrew Kenny, et. al.Andrew Kenny ... Paul M Macdonald
31 Mar 2021
Loss of RanGAP1 drives chromosome instability and rapid tumorigenesis of osteosarcoma.
Yan Gong ... Jun Yang
Developmental Cell | VOL. 58
Yan Gong, et. al.Yan Gong ... Jun Yang
01 Feb 2023
View more papers

More From: Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics

Paper Title
Journal
Date
Author
Retraction notice to Long Noncoding RNA LINC01133 Functions as an miR-422a Sponge to Aggravate the Tumorigenesis of Human Osteosarcoma [Oncology Research 26(3) (2018) 335343
Hai-Feng Zeng ... Hai-Yan Qiu
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics | VOL. 29
Hai-Feng Zeng, et. al.Hai-Feng Zeng ... Hai-Yan Qiu
04 May 2022
STAT3 Polymorphism Associates With mTOR Inhibitor-Induced Interstitial Lung Disease in Patients With Renal Cell Carcinoma.
Kazuhiro Yamamoto ...
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics | VOL. 29
Kazuhiro Yamamoto, et. al.Kazuhiro Yamamoto ...
04 May 2022
Research Progress in Immunotherapy of NSCLC With EGFR-Sensitive Mutations.
Yudie Yang ... Yajie Gao
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics | VOL. 29
Yudie Yang, et. al.Yudie Yang ... Yajie Gao
04 May 2022
Retraction notice to Targeted Silencing of Kim-1 Inhibits the Growth of Clear Cell Renal Cell Carcinoma Cell Line 786-0 In Vitro and In Vivo [Oncology Research 26(7) (2018) 997-1003
Jianping Xu ... Liguo Sun
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics | VOL. 29
Jianping Xu, et. al.Jianping Xu ... Liguo Sun
04 May 2022
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.